Aspartame E951
artificial — Primarily synthetic.
N-(L-α-Aspartyl)-L-phenylalanine 1-methyl ester
CAS: 22839-47-0
Factual Regulatory Reference
This database provides factual regulatory information compiled from official government sources. It does not constitute medical, nutritional, or safety advice. Regulatory status varies by country and is subject to change. Always refer to your local regulatory authority for the most current information.
What Is Aspartame?
Aspartame (E951) is a synthetic low-calorie sweetener approximately 200 times sweeter than sucrose, composed of two amino acids — aspartic acid and phenylalanine — joined by a methyl ester bond; it is produced by chemical synthesis or enzymatic coupling and does not occur in nature. It is widely used in diet sodas, sugar-free chewing gum, low-calorie yogurts and desserts, tabletop sweeteners (sold as NutraSweet and Equal), protein bars, and reduced-calorie foods, and requires mandatory warning labels for people with phenylketonuria (PKU) because it is a source of phenylalanine. Aspartame is approved in the EU, USA (since 1981), Japan, Australia-NZ, and Canada with an ADI of 40 mg/kg body weight per day (EFSA 2013, JECFA 2023); in July 2023, IARC classified aspartame as Group 2B ('possibly carcinogenic to humans') based on limited evidence, while simultaneously JECFA reaffirmed the existing ADI, an unprecedented dual announcement that highlighted the distinction between hazard classification and risk assessment.
? Did You Know?
Beyond food, Aspartame is also used in medicine, household products. Its versatility makes it one of the most multi-purpose chemical compounds in everyday life.
To reach the Acceptable Daily Intake limit, a 60kg adult would need to consume approximately ~13 cans of diet soda (355ml) in a single day. (This is a mathematical illustration, not a safety recommendation.)
Aspartame is fully synthetic — it doesn't exist in nature and is manufactured entirely through chemical processes.
Regulatory Analysis
The July 2023 aspartame classification is unprecedented in regulatory science: two bodies operating under the WHO umbrella -- IARC and JECFA -- issued simultaneous but contradictory signals, with IARC assigning a Group 2B 'possibly carcinogenic' label while JECFA reaffirmed the existing 40 mg/kg ADI on the same day. This dual announcement laid bare the structural tension between hazard identification (can this substance cause cancer under any conditions?) and risk assessment (does it cause cancer at actual human exposure levels?), two frameworks that answer fundamentally different questions. The episode has become a case study in how institutional mandates shape scientific conclusions, and how coordinated disclosure can paradoxically amplify public confusion rather than resolve it.
Detailed Regulatory Assessment
European Union (EFSA)
Must carry warning for phenylketonuria (PKU) patients; under re-evaluation following IARC classification
Official EFSA LinkUnited States (FDA)
Products must carry PKU warning; approved since 1981
Japan (MHLW)
Must carry PKU warning
Acceptable Daily Intake (ADI)
International Standard (JECFA)
mg/kg body weight per day
European Standard (EFSA)
Everyday Perspective
For a 60kg adult, this limit is roughly equivalent to consuming:
Natural Occurrence
This additive is not known to occur naturally in significant quantities.
Manufacturing
Synthesized by coupling aspartic acid with phenylalanine methyl ester, or produced using enzymatic methods.
Applications Beyond Food
Used in chewable tablets, liquid medicines, and vitamin supplements.
Sold as table-top sweetener (Equal, NutraSweet)
Safety & Regulatory History
Full Timeline →Aspartame discovered accidentally by chemist James M. Schlatter while developing anti-ulcer drug.
FDA initially approved aspartame for limited uses, but approval was stayed pending further review.
FDA approved aspartame for dry goods and tabletop sweetener use.
FDA approved aspartame for use in carbonated beverages.
FDA approved aspartame as a general purpose sweetener for all foods and beverages.
EFSA Scientific Committee on Food confirmed safety and ADI of 40 mg/kg bw/day.
EFSA completed comprehensive risk assessment, concluded aspartame and its breakdown products are ...
IARC classified aspartame as 'possibly carcinogenic to humans' (Group 2B) based on limited evidence.
JECFA (meeting same month as IARC) reaffirmed ADI of 0-40 mg/kg bw/day, concluded no reason to ch...
WHO and EFSA clarified that aspartame remains safe at current exposure levels despite IARC Group ...
Aspartame discovered accidentally by chemist James M. Schlatter while developing anti-ulcer drug.
FDA initially approved aspartame for limited uses, but approval was stayed pending further review.
FDA approved aspartame for dry goods and tabletop sweetener use.
FDA approved aspartame for use in carbonated beverages.
FDA approved aspartame as a general purpose sweetener for all foods and beverages.
EFSA Scientific Committee on Food confirmed safety and ADI of 40 mg/kg bw/day.
EFSA completed comprehensive risk assessment, concluded aspartame and its breakdown products are safe at current exposure levels. Confirmed ADI of 40 mg/kg bw/day.
IARC classified aspartame as 'possibly carcinogenic to humans' (Group 2B) based on limited evidence.
JECFA (meeting same month as IARC) reaffirmed ADI of 0-40 mg/kg bw/day, concluded no reason to change previously established safe intake levels.
WHO and EFSA clarified that aspartame remains safe at current exposure levels despite IARC Group 2B classification. IARC identifies hazard, not risk at typical consumption.